-
Loading metrics
Open Access
Peer-reviewed
Research Article
Polycystin-1 is required for insulin-like growth factor 1-induced cardiomyocyte hypertrophy
-
Carolina Fernández,
Roles Conceptualization, Data curation, Formal analysis
Affiliation Faculty of Chemical & Pharmaceutical Sciences & Faculty of Medicine, Advanced Center for Chronic Diseases (ACCDiS), Universidad de Chile and Pontificia Universidad Católica de Chile, Santiago de Chile, Chile
⨯ -
Natalia Torrealba,
Roles Data curation, Formal analysis, Methodology
Affiliations Faculty of Chemical & Pharmaceutical Sciences & Faculty of Medicine, Advanced Center for Chronic Diseases (ACCDiS), Universidad de Chile and Pontificia Universidad Católica de Chile, Santiago de Chile, Chile, Laboratory of Tumour Resistance, Institute of Biotechnology of the Czech Academy of Sciences, Vestec, Czech Republic
⨯ -
Francisco Altamirano,
Roles Data curation, Formal analysis, Investigation
Affiliations Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America, Department of Cardiovascular Sciences, DeBakey Heart & Vascular Center Houston Methodist Research Institute, Houston, Texas, United States of America, Department of Cardiothoracic Surgery, Weill Cornell Medical College, Cornell University, Ithaca, New York, United States of America
⨯ -
Valeria Garrido-Moreno,
Roles Data curation, Formal analysis
Affiliation Faculty of Chemical & Pharmaceutical Sciences & Faculty of Medicine, Advanced Center for Chronic Diseases (ACCDiS), Universidad de Chile and Pontificia Universidad Católica de Chile, Santiago de Chile, Chile
⨯ -
César Vásquez-Trincado,
Roles Data curation, Formal analysis, Investigation
Affiliation Faculty of Chemical & Pharmaceutical Sciences & Faculty of Medicine, Advanced Center for Chronic Diseases (ACCDiS), Universidad de Chile and Pontificia Universidad Católica de Chile, Santiago de Chile, Chile
⨯ -
Raúl Flores-Vergara,
Roles Formal analysis, Investigation
Affiliations Faculty of Chemical & Pharmaceutical Sciences & Faculty of Medicine, Advanced Center for Chronic Diseases (ACCDiS), Universidad de Chile and Pontificia Universidad Católica de Chile, Santiago de Chile, Chile, Facultad de Medicina, Programa de Fisiología y Biofísica, Instituto de Ciencias Biomédicas, Universidad de Chile, Santiago de Chile, Chile
⨯ -
Camila López-Crisosto,
Roles Data curation, Formal analysis
Affiliations Faculty of Chemical & Pharmaceutical Sciences & Faculty of Medicine, Advanced Center for Chronic Diseases (ACCDiS), Universidad de Chile and Pontificia Universidad Católica de Chile, Santiago de Chile, Chile, Faculty of Medicine, Division of Cardiovascular Diseases, Pontificia Universidad Católica de Chile, Santiago de Chile, Chile
⨯ -
María Paz Ocaranza,
Roles Formal analysis, Writing – original draft
Affiliations Faculty of Chemical & Pharmaceutical Sciences & Faculty of Medicine, Advanced Center for Chronic Diseases (ACCDiS), Universidad de Chile and Pontificia Universidad Católica de Chile, Santiago de Chile, Chile, Faculty of Medicine, Division of Cardiovascular Diseases, Pontificia Universidad Católica de Chile, Santiago de Chile, Chile, Center for New Drugs for Hypertension (CENDHY), Pontificia Universidad Católica de Chile, Santiago de Chile, Chile
⨯ -
Mario Chiong,
Roles Formal analysis, Writing – original draft
Affiliation Faculty of Chemical & Pharmaceutical Sciences & Faculty of Medicine, Advanced Center for Chronic Diseases (ACCDiS), Universidad de Chile and Pontificia Universidad Católica de Chile, Santiago de Chile, Chile
⨯ -
Zully Pedrozo ,
Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Writing – original draft, Writing – review & editing
* E-mail: zpedrozo@med.uchile.cl (ZP); slavander@uchile.cl (SL)
Affiliations Faculty of Chemical & Pharmaceutical Sciences & Faculty of Medicine, Advanced Center for Chronic Diseases (ACCDiS), Universidad de Chile and Pontificia Universidad Católica de Chile, Santiago de Chile, Chile, Facultad de Medicina, Programa de Fisiología y Biofísica, Instituto de Ciencias Biomédicas, Universidad de Chile, Santiago de Chile, Chile
⨯ -
Sergio Lavandero
Roles Conceptualization, Formal analysis, Funding acquisition, Writing – original draft, Writing – review & editing
* E-mail: zpedrozo@med.uchile.cl (ZP); slavander@uchile.cl (SL)
Affiliations Faculty of Chemical & Pharmaceutical Sciences & Faculty of Medicine, Advanced Center for Chronic Diseases (ACCDiS), Universidad de Chile and Pontificia Universidad Católica de Chile, Santiago de Chile, Chile, Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America, Corporación Centro de Estudios Científicos de las Enfermedades Crónicas (CECEC), Santiago de Chile, Chile
⨯
Polycystin-1 is required for insulin-like growth factor 1-induced cardiomyocyte hypertrophy
- Carolina Fernández,
- Natalia Torrealba,
- Francisco Altamirano,
- Valeria Garrido-Moreno,
- César Vásquez-Trincado,
- Raúl Flores-Vergara,
- Camila López-Crisosto,
- María Paz Ocaranza,
- Mario Chiong,
- Zully Pedrozo
- Published: August 18, 2021
- https://doi.org/10.1371/journal.pone.0255452